New Therapeutics in Retinal Disease
COPE #85689-TD
Event #126507


This course will update the attendees on the current concepts and treatment of retinal disease based on recent clinical trials and approval of new therapeutic options for AMD, DME etc.


• The attendee will learn current updates in pharmaceutical treatment of retinal disease

• The attendee will learn about treatment options that increase durability and duration of care

• The attendees will learn about the new treatment for Geographic Atrophy (GA) secondary to AMD.


Watch course video online

Text material

Course slides for you to follow along


Take and pass the exam with a 70% or higher


Download CE certificate
Get to know our speakers

Dr. Jay Haynie

Jay M. Haynie, OD, FAAO


Dr. Jay M. Haynie is a graduate of Pacific University College of Optometry and completed a residency at American Lake Veterans Hospital in 1993 where the focus was on the diagnosis and management of ocular disease.  He served as the Executive Clinical Director of Retina and Macula Specialists until 2018 after which time he joined Sound Retina in Tacoma Washington. He is an adjunct clinical professor at Pacific University College of Optometry, a Fellow of the American Academy of Optometry and a fellow of the Optometric Retina Society. He is a clinical investigator and continues to be involved in clinical studies regarding retinal disease management, both as a principle and sub-investigator.  He is a published author and has become a nationally recognized speaker on advances in technology and the management of retinal disease.